Latest Financial Guidance News

Mach7 Technologies maintains its FY25 revenue growth guidance with strong recurring revenue gains, despite a modest shortfall in contracted annual recurring revenue. The company also advances its share buyback program, signaling confidence in its financial position.

EQ Resources has successfully raised A$4 million through a strongly supported placement to fund expansion and optimization at its Mt Carbine tungsten mine, reinforcing its position amid global supply challenges.

IAG has revised its FY25 financial guidance upward, citing a $200 million reduction in expected natural perils costs, including significant claims from recent NSW floods. This update lifts profit and margin forecasts amid steady premium growth.

Superloop Limited has raised its FY25 underlying EBITDA guidance to at least $91 million, significantly surpassing earlier forecasts and signaling robust business momentum.

Metal Powder Works has doubled its production capacity and launched continuous 24/7 automated manufacturing at its Pittsburgh facility, marking a significant leap in operational efficiency and cost competitiveness.

Sports Entertainment Group upgrades its FY25 EBITDA forecast to $9m-$10m, driven by strategic divestments and new media initiatives, setting the stage for continued growth in FY26.

PointsBet Holdings Limited has updated its FY25 financial outlook, signalling that both revenue and EBITDA are expected to land at the bottom of previously forecasted ranges.

GTN Limited has revised down its FY25 revenue and adjusted EBITDA guidance, citing one-off corporate expenses and strategic investments, while maintaining strong cash flow and capital management plans.

Orpheus Uranium announces key board retirements and leadership shifts as it intensifies its focus on uranium exploration and project acquisitions.

Tasmea Limited forecasts a robust 34% increase in net profit after tax for FY26, driven by a record order book and strategic acquisitions, while reaffirming its FY25 earnings guidance.

Cogstate Ltd has upgraded its FY25 financial guidance, projecting a 20-24% revenue increase and nearly doubling profit before tax compared to last year.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.